Clinicopathological data obtained from the TCGA CRC cohort, including gender, age, BMI, serum carcinoembryonic antigen (CEA) level, perineural invasion, lymphatic invasion, residual tumor, TNN classification, and OS event, were analyzed. This evidence concerns the gene CEACAM5 and neoplasm.